aTyr Pharma | LIFE - Ebitda

Stock Price
0.50
Daily Change
-0.06 -9.98%
Monthly
-39.31%
Yearly
-84.59%
Q2 Forecast
0.49

aTyr Pharma reported $25.85M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Ardelyx USD 6.02M 447K Dec/2025
aTyr Pharma USD 25.85M 52.43M Dec/2025
Biogen USD 649.7M 76.5M Mar/2026
Bristol-Myers Squibb USD 2.88B 1.36B Dec/2025
Cipla INR 12.55B 6.4B Dec/2025
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -7.89M 536K Sep/2025
CSL USD 3.13B 1.17B Dec/2025
Curis USD -12.3M 231K Sep/2023
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
Grifols EUR 482.04M 7.04M Sep/2025
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Novartis USD 5.3B 530M Mar/2026
Roche Holding CHF 12.68B 2.36B Jun/2024
United Therapeutics USD 379.5M 83.4M Dec/2025
Xoma USD 2.52M 7.98M Jun/2024